- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Silver47 Exploration
Purpose Bitcoin ETF
Jindalee Lithium
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
CB2 Insights to Host Q12019 Earnings Call on May 31, 2019
CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its Q1 2019 earnings call on Friday, May 31, 2019 at 9:00 a.m. Eastern Daylight Time (EDT).
CB2 Insights (CSE:CBII, OTCQB:CBIIF), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its Q1 2019 earnings call on Friday, May 31, 2019 at 9:00 a.m. Eastern Daylight Time (EDT).
CB2 will issue a press release and file its earnings on SEDAR at approximately 4:05 p.m. EDT on Thursday, May 30, 2019. The press release will be available at the same time on the Company’s website at www.cb2insights.com/news.
Access via Phone (audio only):
A replay of the earnings call will be available on the company’s website 24 hours after the call takes place.
Submitting Questions:
Those interested in submitting questions for the earnings call can do so by emailing investors@cb2inisghts.com prior to the start of the call. CB2 Insights will attempt to answer all questions submitted, however some questions may not be answered during the call due to time constraints.
About CB2 Insights
CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare. We do so by gathering data and creating objective real-world evidence through our proprietary software and service brands. Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry.
For more information please visit www.cb2insights.com.
No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.
Primary Contact: Dan Thompson Chief Marketing Officer 1.416.670.9316 For Investor Inquiries: Sean Peasgood +1.647.362.8286
Click here to connect with CB2 Insights (CSE:CBII, OTCQB:CBIIF) for an Investor Presentation.
Source: www.globenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.